CVX — Chevron Corporation

Sentiment is clearly bullish. Q2 2026 (reported 2026-07-31) was a blowout: ~$12.1B net income / $6.11 diluted EPS, revenue ~$67B, record 97% U.S. crude-unit utilization, 4.07 MBOED worldwide production, and $6.5B returned to shareholders - the 16th consecutive quarter above $5B. The August 2026 Microsoft power agreement (20 years, 2.67GW, Project Kilby) and Angola/Venezuela expansion gave the bulls a growth-and-diversification narrative on top of the beat. As of 2026-09-13, RSI(14) was 68.95, the price sat 3.68% above its 20-day SMA, 9.92% above its 50-day and 17.39% above its 200-day, and the analyst consensus was Buy with an average target of $216.92. The caution flag inside the bullishness: at $214.01 the stock is already within ~1.5% of the consensus target, meaning the good news is largely in the price.

Earnings power eroded for roughly two years and then spiked for reasons that need verification. Diluted EPS fell from $3.48 (2023-09-30) into a $1.22-$2.97 band across 2024, then settled into a weaker $1.39-$2.00 band across all four quarters of 2025, bottoming at $1.11 in Q1 2026 - before printing $6.11 in Q2 2026. Revenue tells the same story: ~$46-52B per quarter through 2023-2025, $47.6B in Q1 2026, then $67.2B in Q2 2026, a +41% sequential jump the deterministic score's own notes flag as likely non-organic. The tell is margin: operating margin was 8.8%, 8.9% and 9.1% in the three quarters ending 2025-12-31, 6.8% in Q1 2026, then 32.0% in Q2 2026; gross margin jumped to 45.5% of revenue versus a consistent ~29-31% elsewhere. Free cash flow follows the same jagged path: $4.94B (2025-09-30), $5.53B (2025-12-31), -$1.55B (2026-03-31), then $18.10B (2026-06-30). Structurally, the Hess deal shows up as a balance-sheet step-change - total assets $250.8B at 2025-06-30 to $326.5B at 2025-09-30, long-term debt $23.3B to $38.0B, equity $146.4B to $189.8B. Bottom line: the underlying 2024-2025 trend was decelerating, Q2 2026 was a real operating beat but is not a clean run-rate, and extrapolating it would be a mistake.

Mixed, leaning full. As of 2026-09-13 the stock trades at 20.44x trailing EPS of $10.45 versus a 5-year average trailing P/E of 15.0x, and at 2.04x sales versus a 5-year average of 1.44x - both clearly rich against its own history. P/B is 2.22 and EV/EBITDA is 8.09, above the ~6.5-7.5x integrated-major norm. The one cheap-looking metric, a PEG of 0.597, is an artifact: it divides a rich P/E by a growth rate computed off a depressed and distorted trailing base. On the $16.08 next-FY consensus EPS the forward multiple is only ~13.3x, which would be cheap versus the 15.0x average - so the entire valuation question collapses to whether $16.08 is real. My read is that it is aggressive, because the four quarters before Q2 2026 averaged roughly $1.60 in EPS. Fair to rich, not cheap.

The $214.01 price is already underwriting the forward estimate arriving. At 20.4x trailing you are paying a premium multiple on earnings that contain a one-off-heavy quarter; at ~13.3x the $16.08 consensus you are paying a normal multiple on earnings that have not shown up yet. Q3 2026, due 2026-10-30 with consensus near $4.77, is the single most important data point: a print in the $4.50-5.00 range confirms the step-change and roughly justifies today's multiple, while a reversion toward the $1.50-2.50 quarterly band that prevailed through 2025 would make the stock look expensive quickly and force a de-rating. Watch two things - the gap between adjusted and reported EPS (Q2 2026's outsized 32% operating margin suggests something non-recurring ran through it), and the accruals ratio, which at -3.2% as of 2026-06-30 is a healthy, cash-backed signal and a genuine comfort.

Extended. As of 2026-09-13, RSI(14) was 68.95 - just shy of overbought - and the price sat 3.68% above its 20-day SMA (roughly $206), 9.92% above its 50-day (roughly $195) and 17.39% above its 200-day (roughly $182). That is a clean, persistent uptrend rather than a range, but the stretch above the 50- and 200-day is the kind of extension that typically precedes consolidation, and the stock is only about 1.5% below its 52-week high of $217.40. Timing implication: this is not an entry point for new money; a pullback into the $206 (20-day) or $195 (50-day) zone would offer materially better risk/reward without breaking the trend.

• Crude price and OPEC+ supply: realized margins are levered to Brent/WTI; Middle East tension and Strait of Hormuz transit risk have kept a risk premium in prices, and de-escalation is a direct downside to earnings.
• Refining crack spreads: Q2 2026's record 97% U.S. crude-unit utilization flattered downstream results, but cracks normalize quickly and could reverse that tailwind within a quarter or two.
• Discount rates and bond-proxy competition: with a 0.49 beta and a 3.43% dividend yield (~$7.33/share annualized at $214.01), CVX competes directly with fixed income; a higher-for-longer rate path caps multiple expansion even if earnings hold.
• Sanctions and licensing geopolitics: expansion in Angola's Block 0 and in Venezuelan heavy oil adds reserves but exposes Chevron to license changes and sanctions-policy shifts outside its control.
• AI/data-center power demand and cost inflation: the 2.67GW Microsoft Project Kilby agreement opens fixed-fee, non-commodity revenue, but field-services and labor inflation are pressuring project costs and the $3-4B cost-reduction program is the offset.

• Q3 2026 earnings on 2026-10-30 with consensus near $4.77 EPS - the decisive test of whether Q2 2026's $6.11 is repeatable or one-off.
• Hess integration, Guyana and Permian ramp - production updates against the 4.07 MBOED Q2 2026 base, plus delivery of the $3-4B structural cost-reduction target.
• Execution on the 2.67GW Microsoft Project Kilby data-center power contract - evidence that non-commodity fixed-fee cash flow is a genuine second leg rather than a headline.
• Capital-return cadence - a 17th consecutive quarter above $5B of buybacks plus dividends, and any acceleration of the repurchase given the strong Q2 2026 free cash flow.
• Oil-price headlines - OPEC+ decisions and Middle East risk premium can move the stock faster than quarterly results in either direction.

• Oil price de-escalation: the current earnings run-rate leans on elevated prices; normalizing Middle East risk hits realized prices, cash flow and the multiple simultaneously.
• Earnings-quality risk: Q2 2026's 32% operating margin and $18.1B of free cash flow look one-off-inflated versus the ~7-9% margins and $1-6B FCF of the preceding quarters; a reversion would make 20.4x trailing look very different.
• Valuation and entry risk: 20.4x trailing against a 15.0x 5-year average, with the price within 1.5% of its 52-week high and RSI at 68.95, leaves very little cushion if anything disappoints.
• Integration and execution risk: absorbing Hess and standing up a first-of-its-kind AI power business are both somewhat outside Chevron's core competency and carry regulatory, counterparty and delivery risk.
• Weak returns on capital: trailing ROIC of 3.6% and ROE of 6.6% are thin, and while purchase accounting and impairments explain part of that, it leaves limited buffer against cost inflation or project overruns.

Chevron is a genuinely good business - 0.195 debt-to-equity, a 1.36 current ratio, a 3.43% dividend, 16 consecutive quarters of $5B+ shareholder returns and a 0.49 beta - but as of 2026-09-13 at $214.01 it is a full-price stock: 20.4x trailing earnings and 2.04x sales versus 5-year averages of 15.0x and 1.44x, with RSI at 68.95 and the price just below its record high. My own valuation work lands around $208, so there is no margin of safety at today's quote. Own it for the dividend and the Hess/Guyana production story if you already hold it, but do not chase it here - a pullback into the $195-206 zone is where the risk/reward actually turns favorable.

I applied 13.5x to a ~$15.20 forward EPS - roughly a 5% haircut to the $16.08 next-FY consensus to reflect the one-off-heavy Q2 2026 and the large gap between that estimate and the ~$1.11-$2.00 quarterly EPS run-rate of the four preceding quarters - which yields about $205. Cross-checking with 8.0x EV/EBITDA on ~$56.6B of EBITDA (derived from the $457.8B enterprise value and the given 8.09x ratio) implies roughly $211 per share on ~1.99B shares. I take the ~$208 midpoint as my independent fair value.